ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC)

Lobbying for ARDELYX, INC. · Biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $90,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Medicare/Medicaid

Issues related to coverage and reimbursement under Medicare Part D.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem